Buyouts

Investing in business transformation
Icons dark green

200+ direct/co-investments*

Our team focuses on small and mid-market companies, investing both directly and in partnership with specialised private equity managers

Icons dark green

Investments spanning a range of industries

Portfolios are diversified across five key sectors: healthcare, technology, consumer, business services and industrials

Icons dark green

A track record that demonstrates consistent value creation

A strong track record of performance and value-add capabilities, proven across multiple economic cycles

Seizing the opportunity for change

Investors come to us for our experience and focus on small and mid-market buyout investments, sourced primarily from family and founder-owners. We seek to drive growth and transformation in the businesses we own. We leverage our global platform, and a network of specialised managers, to access high-potential investments.

Why it makes sense to tap into lower mid-market buyouts

Schroders Capital is a seasoned buyout investor. We focus on specialised market segments, with a global perspective. Our investors benefit from a network that we’ve developed since 1997. We believe the small and mid-market is where the best opportunities to maximise return can be found. Companies in this segment are less reliant on financial engineering, instead generating upside through operational improvements and transformed growth.

Global reach. Local networks.

Our global, institutional platform supports strong local teams working alongside specialist GPs. Through these partnerships we are a respected investor and valued for the experience and networks we can bring to those companies.

Private equity

Construction products distributor focused on high growth markets

Coastal Construction | North America

A value-added distributor of construction products and materials. With a focus on construction waterproofing, they develop deep customer relationships through specific expertise, product selection guidance, design support and local availability.

  • Year of investment

    2018

  • Geography

    North America

  • Sector

    Industrial

  • Type

    Buyout

  • Disclaimer

    The company shown is for illustrative purposes only and not a recommendation to buy or sell.

Private equity

Specialty pharmaceutical company focused on innovative dosage forms

Azurity Pharmaceuticals | North America

Azurity is a leading specialist pharmaceutical company. Azurity offers dosage innovation and patient centric manufacturing and has substantial scale and synergies from complementary products, pipelines and capabilities.

  • Year of investment

    2021

  • Geography

    North America

  • Sector

    Healthcare

  • Type

    Buyout

  • Disclaimer

    The company shown is for illustrative purposes only and not a recommendation to buy or sell.

Meet our buyouts team

A long-serving, stable team of respected private equity professionals, with diverse backgrounds and highly relevant experience in sourcing, evaluating and executing buyout investments.

Our other areas of expertise in private equity

Slide 1 of 3

BlueOrchard

We are impact investment pioneers with a 20+ year track record and a global reach of over 280 million people. Our goal? Combining social and environmental impact with a positive financial return. We have invested long-term in more than 100 emerging and frontier markets through a network of over 750 financial institutions. Learn about the opportunity for impact and return

*As of 30th June 2023. Source: Schroders Capital

Contact Schroders Capital
Follow us

Past performance is not a guide to future performance and may not be repeated. The value of investments and the income from them may go down as well as up and investors may not get back the amounts originally invested. All investments involve risks including the risk of possible loss of principal.